Literature DB >> 25265466

Bactericidal/Permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease.

Clemente J Britto1, Lauren Cohn.   

Abstract

Bactericidal/permeability-increasing protein fold-containing family member A1 (BPIFA1), formerly known as SPLUNC1, is one of the most abundant proteins in respiratory secretions and has been identified with increasing frequency in studies of pulmonary disease. Its expression is largely restricted to the respiratory tract, being highly concentrated in the upper airways and proximal trachea. BPIFA1 is highly responsive to airborne pathogens, allergens, and irritants. BPIFA1 actively participates in host protection through antimicrobial, surfactant, airway surface liquid regulation, and immunomodulatory properties. Its expression is modulated in multiple lung diseases, including cystic fibrosis, chronic obstructive pulmonary disease, respiratory malignancies, and idiopathic pulmonary fibrosis. However, the role of BPIFA1 in pulmonary pathogenesis remains to be elucidated. This review highlights the versatile properties of BPIFA1 in antimicrobial protection and its roles as a sensor of environmental exposure and regulator of immune cell function. A greater understanding of the contribution of BPIFA1 to disease pathogenesis and activity may clarify if BPIFA1 is a biomarker and potential drug target in pulmonary disease.

Entities:  

Keywords:  BPIFA1; SPLUNC1; airway epithelium; host protection; inflammation

Mesh:

Substances:

Year:  2015        PMID: 25265466      PMCID: PMC4491141          DOI: 10.1165/rcmb.2014-0297RT

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  87 in total

Review 1.  Antimicrobial peptides: general overview and clinical implications in human health and disease.

Authors:  Eduardo Guaní-Guerra; Teresa Santos-Mendoza; Saúl O Lugo-Reyes; Luis M Terán
Journal:  Clin Immunol       Date:  2010-01-29       Impact factor: 3.969

2.  Identification of human nasal mucous proteins using proteomics.

Authors:  Begoña Casado; Lewis K Pannell; Paolo Iadarola; James N Baraniuk
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

3.  Cationic polypeptides are required for antibacterial activity of human airway fluid.

Authors:  Alexander M Cole; Hsiang-I Liao; Olga Stuchlik; Jason Tilan; Jan Pohl; Tomas Ganz
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

4.  MAPK/AP-1 activation mediates TLR2 agonist-induced SPLUNC1 expression in human lung epithelial cells.

Authors:  Jyoti Thaikoottathil; Hong Wei Chu
Journal:  Mol Immunol       Date:  2011-09-06       Impact factor: 4.407

5.  Decreased SPLUNC1 expression is associated with Pseudomonas infection in surgically treated chronic rhinosinusitis patients who may require repeated sinus surgery.

Authors:  Yung-An Tsou; Chuan-Mu Chen; Tzu-Chieh Lin; Fang-Wei Hu; Chin-Jann Tai; Hui-Chen Chen; Te-Huei Yeh; Horng-Jyh Harn; Ming-Hsui Tsai; Chia-Ing Jan
Journal:  Laryngoscope       Date:  2013-01-31       Impact factor: 3.325

6.  Dual acute proinflammatory and antifibrotic pulmonary effects of short palate, lung, and nasal epithelium clone-1 after exposure to carbon nanotubes.

Authors:  Y Peter Di; Alexey V Tkach; Naveena Yanamala; Shyla Stanley; Shengli Gao; Michael R Shurin; Elena R Kisin; Valerian E Kagan; Anna Shvedova
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

7.  Effect of SPLUNC1 protein on the Pseudomonas aeruginosa and Epstein-Barr virus.

Authors:  Hou-De Zhou; Xiao-Ling Li; Gui-Yuan Li; Ming Zhou; Hua-Ying Liu; Yi-Xing Yang; Tan Deng; Jian Ma; Shou-Rong Sheng
Journal:  Mol Cell Biochem       Date:  2007-11-30       Impact factor: 3.396

8.  SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage.

Authors:  Agustin Garcia-Caballero; Julia E Rasmussen; Erol Gaillard; Michael J Watson; John C Olsen; Scott H Donaldson; M Jackson Stutts; Robert Tarran
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-18       Impact factor: 11.205

9.  Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection.

Authors:  Sameera Sayeed; Laura Nistico; Claudette St Croix; Y Peter Di
Journal:  Infect Immun       Date:  2012-11-06       Impact factor: 3.441

10.  Airway epithelial NF-κB activation promotes Mycoplasma pneumoniae clearance in mice.

Authors:  Di Jiang; Mark L Nelson; Fabienne Gally; Sean Smith; Qun Wu; Maisha Minor; Stephanie Case; Jyoti Thaikoottathil; Hong Wei Chu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  26 in total

1.  BPI fold-containing family a member 2 as a biomarker of acute kidney injury-close but no (clinical) cigar?

Authors:  Patrick M Honore; David De Bels; Herbert D Spapen
Journal:  Ann Transl Med       Date:  2018-05

2.  BPIFA1 regulates lung neutrophil recruitment and interferon signaling during acute inflammation.

Authors:  Clemente J Britto; Naiqian Niu; Sara Khanal; Luai Huleihel; Jose D Herazo-Maya; Alison Thompson; Maor Sauler; Martin D Slade; Lokesh Sharma; Charles S Dela Cruz; Naftali Kaminski; Lauren E Cohn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

3.  Antimicrobial peptides alter early immune response to influenza A virus infection in C57BL/6 mice.

Authors:  Kim S LeMessurier; Yanyan Lin; Jonathan A McCullers; Amali E Samarasinghe
Journal:  Antiviral Res       Date:  2016-08-13       Impact factor: 5.970

4.  Profiling Autoantibodies against Salivary Proteins in Sicca Conditions.

Authors:  P D Burbelo; E M N Ferré; A Chaturvedi; J A Chiorini; I Alevizos; M S Lionakis; B M Warner
Journal:  J Dent Res       Date:  2019-05-16       Impact factor: 6.116

5.  A protein interaction landscape of breast cancer.

Authors:  Minkyu Kim; Jisoo Park; Mehdi Bouhaddou; Kyumin Kim; Ajda Rojc; Maya Modak; Margaret Soucheray; Michael J McGregor; Patrick O'Leary; Denise Wolf; Erica Stevenson; Tzeh Keong Foo; Dominique Mitchell; Kari A Herrington; Denise P Muñoz; Beril Tutuncuoglu; Kuei-Ho Chen; Fan Zheng; Jason F Kreisberg; Morgan E Diolaiti; John D Gordan; Jean-Philippe Coppé; Danielle L Swaney; Bing Xia; Laura van 't Veer; Alan Ashworth; Trey Ideker; Nevan J Krogan
Journal:  Science       Date:  2021-10-01       Impact factor: 63.714

6.  Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease.

Authors:  Shawn T Terryah; Robert C Fellner; Saira Ahmad; Patrick J Moore; Boris Reidel; Juliana I Sesma; Christine S Kim; Alaina L Garland; David W Scott; Juan R Sabater; Jerome Carpenter; Scott H Randell; Mehmet Kesimer; William M Abraham; William J Arendshorst; Robert Tarran
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-05       Impact factor: 5.464

7.  Crystal structure of the mouse innate immunity factor bacterial permeability-increasing family member A1.

Authors:  Michael S Little; Matthew R Redinbo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2018-04-16       Impact factor: 1.056

8.  SPLUNC1: a novel marker of cystic fibrosis exacerbations.

Authors:  Sara Khanal; Megan Webster; Naiqian Niu; Jana Zielonka; Myra Nunez; Geoffrey Chupp; Martin D Slade; Lauren Cohn; Maor Sauler; Jose L Gomez; Robert Tarran; Lokesh Sharma; Charles S Dela Cruz; Marie Egan; Theresa Laguna; Clemente J Britto
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 33.795

9.  Structural Features Essential to the Antimicrobial Functions of Human SPLUNC1.

Authors:  William G Walton; Saira Ahmad; Michael S Little; Christine S K Kim; Jean Tyrrell; Qiao Lin; Y Peter Di; Robert Tarran; Matthew R Redinbo
Journal:  Biochemistry       Date:  2016-05-17       Impact factor: 3.162

Review 10.  Killing three birds with one BPI: Bactericidal, opsonic, and anti-inflammatory functions.

Authors:  Jomkuan Theprungsirikul; Sladjana Skopelja-Gardner; William F C Rigby
Journal:  J Transl Autoimmun       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.